A review of methotrexate-associated hepatotoxicity

Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study

(2013) Ella A.M. van der Voort et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Incidence of Liver Toxicity in Inflammatory Bowel Disease Patients Treated with Methotrexate: A Meta-Analysis of Clinical Trials

(2011) Nabeel Khan et al.   INFLAMMATORY BOWEL DISEASES

Changes in Liver Biochemistry During Methotrexate Use for Inflammatory Bowel Disease

(2010) Marc R Fournier et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic

(2010) J. Barker et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

(2009) Paolo Gisondi et al.   JOURNAL OF HEPATOLOGY

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference

(2009) Robert E. Kalb et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

(2009) D Pathirana et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?

(2008) K. Lindsay et al.   RHEUMATOLOGY